皮肤冠状动脉干预后死亡:来自 PROGRESS-COMPLICATIONS 注册表的数据
Dimitrios Strepkos1, Michaella Alexandrou1, Deniz Mutlu1
1Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.
The American journal of cardiology
|February 15, 2026
概括
穿皮冠状动脉干预 (PCI) 的死亡率低于0.5%,但复杂病变的死亡率更高. 心脏性休克是PCI后的主要死亡原因,通常需要机械支持.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 临床结果 临床结果
背景情况:
- 皮肤冠状动脉干预 (PCI) 相关的死亡率仍未得到充分研究.
- 了解PCI相关的死亡对于改善患者的治疗结果至关重要.
- 关于PCI后死亡的特征和原因的数据有限.
研究的目的:
- 调查与穿皮冠状动脉干预 (PCI) 相关的发生率,特征和死亡原因.
- 确定与PCI相关死亡相关的风险因素和临床表现.
- 分析接受PCI的患者死亡的主要驱动因素.
主要方法:
- 从PROGRESSCOMPLICATIONS注册表中分析了22503名接受PCI的患者.
- 检查患者的人口统计,并发症,病变复杂性和程序细节.
- 死亡原因的分类,包括周围手术,早期和晚期PCI后死亡.
主要成果:
- 总体PCI相关的死亡率为0.5% (115例死亡).
- 在患有复杂冠状动脉病变和急性表现 (NSTEMI/STEMI) 的患者中,死亡的频率更高.
- 心脏性休克是主要的死亡原因 (80.9%),通常与急性心肌梗塞有关,需要左心室辅助装置 (LVAD) 支持.
结论:
- 在PCI后的外科手术死亡发生在0.5%的病例中,特别是在复杂的病变和急性表现的情况下.
- 心脏性休克是PCI后死亡的主要原因.
- 在因心脏性休克死亡的患者中观察到高比例的LVAD使用率.
更多相关视频
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
4.6K
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
9.7K
相关概念视频
01:21Cardiac Catheterization II: Right Heart Catheterization
1.2K
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
1.2K
01:28Acute Coronary Syndrome IV: Interprofessional Care
309
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
309
01:27Coronary Artery Disease V: Interprofessional Care
307
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
307
01:28Cardiac Catheterization I: Pre-Procedure Overview
1.6K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
1.6K
01:30Acute Coronary Syndrome I: Introduction
1.1K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.1K
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
492
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
492